Latest Blog Posts

All Blog Posts

  • Our CEO Dr. Dontabhaktuni Recognized by HER FORWARD Magazine

    Our CEO Dr. Dontabhaktuni Recognized by HER FORWARD Magazine

    This workshop will equip participants with the skills and knowledge necessary to excel in non-compartmental analysis (NCA). NCA is a method to describe pharmacokinetic data used to assess how a drug behaves in the body. It provides key insights into a drug’s absorption, distribution, metabolism, and elimination. By examining parameters like maximum concentration (Cmax), area…

  • Antibody-Drug Conjugates

    Antibody-Drug Conjugates

    The future of Antibody-Drug Conjugates (ADCs) in drug development is promising and dynamic, with numerous exciting prospects on the horizon. Over 100 ADCs are currently under preclinical and early-stage clinical research, highlighting the significant investment in advancing this therapeutic class. Researchers are shifting their focus from targeting oncogenic driver mutations to exploring antigens that are…

  • PharmaPRO Selected in Ten finalists at WBENC NY Pitch Competition

    PharmaPRO Selected in Ten finalists at WBENC NY Pitch Competition

    We are excited to share that PharmaPRO has been selected as the Ten finalists in the WBENC Pitch Competition on Aug 30 2023.It’s with immense pride we share about PharmaPro and our mission—PharmaPro is a unique company that employs only the top pharmaceutical scientists. We are committed to using state-of-the-art science and thinking outside the…

  • Project Dontabhaktuni is Creating a “Virtual Toastmasters Club”

    Project Dontabhaktuni is Creating a “Virtual Toastmasters Club”

    Learning Objectives: Toastmasters is a non-profit organization that helps people improve their communication and leadership skills through a supportive and structured program. An online Toastmasters club is a virtual platform where members meet to practice public speaking, impromptu speaking, and leadership skills. The online format provides a convenient and flexible way for members to participate…

  • Use of AI and ML in Drug Development and Regulatory Submissions

    Use of AI and ML in Drug Development and Regulatory Submissions

    Artificial Intelligence (AI) and Machine Learning (ML) are rapidly changing the landscape of drug development and regulatory submissions. In recent years, these technologies have gained significant attention and have been increasingly adopted by pharmaceutical companies and regulatory agencies alike. Regulatory submissions are a critical aspect of drug development, and they involve submitting a vast amount…